Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents (OCTOPUS)

This study has been completed.
Sponsor:
Collaborators:
B. Braun Melsungen AG
Abbott Vascular
Boston Scientific Corporation
Information provided by (Responsible Party):
Tudor C. Poerner, University of Jena
ClinicalTrials.gov Identifier:
NCT01056744
First received: January 25, 2010
Last updated: February 25, 2013
Last verified: February 2013